Recent Updates
Recently added Catalysts
CRL Positive Sentiment

Charles River Laboratories to Present at William Blair and Jefferies Conferences

Key Takeaway: Charles River Laboratories announced its participation in two upcoming conferences: the William Blair 46th Annual Growth Stock Conference on June 2 and the Jefferies Global Healthcare Conference on June 3. Management will discuss the company's strategic focus and recent business developments. Live webcasts of the presentations will be available on their website.
Price reaction · baseline $180.71 (2026-05-29 close) · hit pre-market · clean, no other CRL news in the window
day 0 close · peak
+0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Charles River Laboratories is actively engaging with investors.
  • The company is showcasing its strategic focus and business developments.
  • Live webcasts will allow broader access to their presentations.

Full Press Release Details

WILMINGTON, Mass. --(BUSINESS WIRE)--Jun. 1, 2026-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 46 th Annual Growth Stock Conference on Tuesday, June 2 nd , at 10:00 a.m. CT ( 11:00 a.m. ET ), and at the Jefferies Global Healthcare Conference on Wednesday, June 3 rd , at 9:55 a.m. ET . Management will present an overview of Charles River’s strategic focus, business developments, and recent trends.
A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com . A webcast replay will be accessible through the same website after each presentation and will remain available for approximately two weeks.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20260601680494/en/
Investor Relations Contact: Todd Spencer Corporate Vice President, Investor Relations 781.222.6455 todd.spencer@crl.com
Source: Charles River Laboratories International, Inc.

Frequently Asked Questions

When will Charles River Laboratories present at the conferences?

Charles River Laboratories will present at the William Blair conference on June 2 and at the Jefferies conference on June 3.

Where can I watch the presentations?

The presentations will be available via live webcast on the Investor Relations section of the Charles River website.

What topics will be covered in the presentations?

Management will discuss the company's strategic focus, business developments, and recent trends.

How long will the webcast replays be available?

Webcast replays will be accessible for approximately two weeks after each presentation.

Last updated: Jun 1, 2026